Prostate Cancer Coverage from Every Angle

Karim Fizazi, MD, PhD, on Chemotherapy vs Endocrine Therapy: Patient-Reported Outcomes

Posted: Tuesday, February 25, 2020

Karim Fizazi, MD, PhD, of the Institut Gustave Roussy, discusses the side effects associated with two classes of medical treatment for prostate cancer, patient-reported outcomes, and how toxicities differ.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.